Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts)
1 competing product in clinical development for Primary MDS (Very Low, Low or Intermediate IPSS-R With <5% Blasts).
Pipeline by Phase
Phase 31
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Roxadustat + Placebo | Astellas Pharma | Phase 3 | Terminated | 32 |